- Home
- NRDY vs ENGN Comparison
NRDY vs ENGN Comparison
Compare NRDY & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRDY
- ENGN
- Stock Information
- Founded
- NRDY 2007
- ENGN 1999
- Country
- NRDY United States
- ENGN Canada
- Employees
- NRDY N/A
- ENGN N/A
- Industry
- NRDY Computer Software: Prepackaged Software
- ENGN
- Sector
- NRDY Technology
- ENGN
- Exchange
- NRDY Nasdaq
- ENGN Nasdaq
- Market Cap
- NRDY 167.7M
- ENGN 191.1M
- IPO Year
- NRDY N/A
- ENGN N/A
- Fundamental
- Price
- NRDY $1.26
- ENGN $3.68
- Analyst Decision
- NRDY Hold
- ENGN Buy
- Analyst Count
- NRDY 9
- ENGN 7
- Target Price
- NRDY $1.83
- ENGN $23.29
- AVG Volume (30 Days)
- NRDY 473.7K
- ENGN 102.4K
- Earning Date
- NRDY 08-07-2025
- ENGN 09-09-2025
- Dividend Yield
- NRDY N/A
- ENGN N/A
- EPS Growth
- NRDY N/A
- ENGN N/A
- EPS
- NRDY N/A
- ENGN N/A
- Revenue
- NRDY $178,378,000.00
- ENGN N/A
- Revenue This Year
- NRDY $4.60
- ENGN N/A
- Revenue Next Year
- NRDY $9.97
- ENGN N/A
- P/E Ratio
- NRDY N/A
- ENGN N/A
- Revenue Growth
- NRDY N/A
- ENGN N/A
- 52 Week Low
- NRDY $0.75
- ENGN $2.65
- 52 Week High
- NRDY $2.18
- ENGN $11.00
- Technical
- Relative Strength Index (RSI)
- NRDY 33.62
- ENGN 50.21
- Support Level
- NRDY $1.22
- ENGN $3.52
- Resistance Level
- NRDY $1.37
- ENGN $3.89
- Average True Range (ATR)
- NRDY 0.08
- ENGN 0.27
- MACD
- NRDY -0.02
- ENGN -0.02
- Stochastic Oscillator
- NRDY 10.33
- ENGN 32.86
About NRDY Nerdy Inc.
Nerdy Inc is a curated direct-to-consumer platform for live online learning. Its proprietary platform leverages technology, including artificial intelligence ("AI"), to connect students, users, parents, guardians, and purchasers of all ages to tutors, instructors, subject matter experts, educators, and other professionals. The company provides learning experiences across numerous subjects and multiple formats, including one-on-one instruction, small group tutoring, large format classes, tutor chat, essay review, adaptive assessments, and self-study tools. The company generates revenue by selling services to learners and institutions for one-on-one instruction and small group tutoring.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.